口服水合剂对冠状动脉造影或介入治疗患者预防造影剂引起的急性肾损伤的疗效。

Nephron Clinical Practice Pub Date : 2014-01-01 Epub Date: 2014-11-04 DOI:10.1159/000365090
Sukru Akyuz, Mehmet Karaca, Tugba Kemaloglu Oz, Servet Altay, Baris Gungor, Baris Yaylak, Selcuk Yazici, Kivilcim Ozden, Gultekin Karakus, Nese Cam
{"title":"口服水合剂对冠状动脉造影或介入治疗患者预防造影剂引起的急性肾损伤的疗效。","authors":"Sukru Akyuz,&nbsp;Mehmet Karaca,&nbsp;Tugba Kemaloglu Oz,&nbsp;Servet Altay,&nbsp;Baris Gungor,&nbsp;Baris Yaylak,&nbsp;Selcuk Yazici,&nbsp;Kivilcim Ozden,&nbsp;Gultekin Karakus,&nbsp;Nese Cam","doi":"10.1159/000365090","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Efficacy of intravenous (IV) volume expansion in preventing contrast-induced acute kidney injury (CI-AKI) is well known. However, the role of oral hydration has not been well established. The aim of this work was to evaluate the efficacy of oral hydration in preventing CI-AKI.</p><p><strong>Methods: </strong>We prospectively randomized 225 patients undergoing coronary angiography and/or percutaneous coronary intervention in either oral hydration or IV hydration groups. Patients who have at least one of the high-risk factors for developing CI-AKI (advanced age, type 2 diabetes mellitus, anemia, hyperuricemia, a history of cardiac failure or systolic dysfunction) were included in the study. All patients had normal renal function or stage 1-2 chronic kidney disease. Patients in the oral hydration group were encouraged to drink unrestricted amounts of fluids freely whereas isotonic saline infusion was performed by the standard protocol in the IV hydration group.</p><p><strong>Results: </strong>CI-AKI occurred in 8/116 patients (6.9%) in the oral hydration group and 8/109 patients (7.3%) in the IV hydration group (p = 0.89). There was also no statistically significant difference between the two groups when different CI-AKI definitions were taken into account.</p><p><strong>Conclusion: </strong>Oral hydration is as effective as IV hydration in preventing CI-AKI in patients with normal kidney function or stage 1-2 chronic kidney disease, and who also have at least one of the other high-risk factors for developing CI-AKI.</p>","PeriodicalId":19094,"journal":{"name":"Nephron Clinical Practice","volume":"128 1-2","pages":"95-100"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000365090","citationCount":"24","resultStr":"{\"title\":\"Efficacy of oral hydration in the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention.\",\"authors\":\"Sukru Akyuz,&nbsp;Mehmet Karaca,&nbsp;Tugba Kemaloglu Oz,&nbsp;Servet Altay,&nbsp;Baris Gungor,&nbsp;Baris Yaylak,&nbsp;Selcuk Yazici,&nbsp;Kivilcim Ozden,&nbsp;Gultekin Karakus,&nbsp;Nese Cam\",\"doi\":\"10.1159/000365090\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Efficacy of intravenous (IV) volume expansion in preventing contrast-induced acute kidney injury (CI-AKI) is well known. However, the role of oral hydration has not been well established. The aim of this work was to evaluate the efficacy of oral hydration in preventing CI-AKI.</p><p><strong>Methods: </strong>We prospectively randomized 225 patients undergoing coronary angiography and/or percutaneous coronary intervention in either oral hydration or IV hydration groups. Patients who have at least one of the high-risk factors for developing CI-AKI (advanced age, type 2 diabetes mellitus, anemia, hyperuricemia, a history of cardiac failure or systolic dysfunction) were included in the study. All patients had normal renal function or stage 1-2 chronic kidney disease. Patients in the oral hydration group were encouraged to drink unrestricted amounts of fluids freely whereas isotonic saline infusion was performed by the standard protocol in the IV hydration group.</p><p><strong>Results: </strong>CI-AKI occurred in 8/116 patients (6.9%) in the oral hydration group and 8/109 patients (7.3%) in the IV hydration group (p = 0.89). There was also no statistically significant difference between the two groups when different CI-AKI definitions were taken into account.</p><p><strong>Conclusion: </strong>Oral hydration is as effective as IV hydration in preventing CI-AKI in patients with normal kidney function or stage 1-2 chronic kidney disease, and who also have at least one of the other high-risk factors for developing CI-AKI.</p>\",\"PeriodicalId\":19094,\"journal\":{\"name\":\"Nephron Clinical Practice\",\"volume\":\"128 1-2\",\"pages\":\"95-100\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000365090\",\"citationCount\":\"24\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nephron Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000365090\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/11/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000365090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/11/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 24

摘要

背景:静脉(IV)容量扩张在预防造影剂诱导的急性肾损伤(CI-AKI)中的作用是众所周知的。然而,口服水合作用尚未得到很好的证实。本研究的目的是评价口服水合液预防CI-AKI的疗效。方法:我们前瞻性地将225例接受冠状动脉造影和/或经皮冠状动脉介入治疗的患者随机分为口服水合组和静脉水合组。至少有一项CI-AKI高危因素(高龄、2型糖尿病、贫血、高尿酸血症、心力衰竭或收缩功能障碍史)的患者被纳入研究。所有患者肾功能正常或1-2期慢性肾病。口服水合组鼓励患者自由饮用不受限制的液体,而静脉水合组则按照标准方案进行等渗盐水输注。结果:口服水合组CI-AKI发生率为8/116例(6.9%),静脉水合组为8/109例(7.3%)(p = 0.89)。当考虑不同CI-AKI定义时,两组之间也没有统计学上的显著差异。结论:对于肾功能正常或1-2期慢性肾病患者,同时存在至少一项其他发生CI-AKI的高危因素,口服水合治疗与静脉水合治疗在预防CI-AKI方面同样有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy of oral hydration in the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention.

Background: Efficacy of intravenous (IV) volume expansion in preventing contrast-induced acute kidney injury (CI-AKI) is well known. However, the role of oral hydration has not been well established. The aim of this work was to evaluate the efficacy of oral hydration in preventing CI-AKI.

Methods: We prospectively randomized 225 patients undergoing coronary angiography and/or percutaneous coronary intervention in either oral hydration or IV hydration groups. Patients who have at least one of the high-risk factors for developing CI-AKI (advanced age, type 2 diabetes mellitus, anemia, hyperuricemia, a history of cardiac failure or systolic dysfunction) were included in the study. All patients had normal renal function or stage 1-2 chronic kidney disease. Patients in the oral hydration group were encouraged to drink unrestricted amounts of fluids freely whereas isotonic saline infusion was performed by the standard protocol in the IV hydration group.

Results: CI-AKI occurred in 8/116 patients (6.9%) in the oral hydration group and 8/109 patients (7.3%) in the IV hydration group (p = 0.89). There was also no statistically significant difference between the two groups when different CI-AKI definitions were taken into account.

Conclusion: Oral hydration is as effective as IV hydration in preventing CI-AKI in patients with normal kidney function or stage 1-2 chronic kidney disease, and who also have at least one of the other high-risk factors for developing CI-AKI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nephron Clinical Practice
Nephron Clinical Practice 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊最新文献
Comparison of Outcomes of In-Centre Haemodialysis Patients between the 1st and 2nd COVID-19 Outbreak in England, Wales, and Northern Ireland: A UK Renal Registry Analysis Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis Contents Vol. 128, 2014 Author Index Vol. 127, No. 1-4, 2014
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1